Free. Unsubscribe any time.
BioXcel Therapeutics, Inc. (BTAI)
BioXcel Therapeutics, Inc. filed 4 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 4 transactions and 39,669 shares. None carries the SEC's AFF10B5ONE flag; all 4 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-05-22, came on the same day as the one before it (2026-05-22) and reports 3 transactions against 3 in the filing before it.
- The sales it reports total 6,845 shares, 285 more than the 6,560 in the filing before it.
- Its 4 filings on file run from 2026-05-22 to 2026-05-22, and state one plan adoption date, 2026-02-03.
Trades in BioXcel Therapeutics, Inc. 4
- Mehta Vimal — 2026-05-20 · S · 19,419 shares
- Rodriguez Javier — 2026-05-20 · S · 6,560 shares
- Steinhart Richard I — 2026-05-20 · S · 6,845 shares
- Yocca Frank — 2026-05-20 · S · 6,845 shares
Adoption dates in BioXcel Therapeutics, Inc. 1
- 2026-02-03 — stated in 4 filings
Results prints in BioXcel Therapeutics, Inc. 0
Trades before a print in BioXcel Therapeutics, Inc. 0
Interval to BioXcel Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 4no later print
Adoption dates BioXcel Therapeutics, Inc. states
- 2026-02-03 in 4 filings
Filing text: “10b5-1 trading plan adopted by the reporting person on February 3, 2026”
Sources: SEC EDGAR full-text search and the SEC submissions API.